Sanofi currently has seven production bases in China, including Beijing Pharmaceutical Factory, Hangzhou Pharmaceutical Factory, Hangzhou Sanofi Minsheng Health Pharmaceutical Factory, Tangshan Health Pharmaceutical Factory, Shenzhen Sanofi Pasteur Vaccine Factory, Melia Nanchang Animal Health Factory and Melia Nanjing Animal Health Factory.
Sanofi China R&D Center was established in 2008, focusing on drug research and development from target discovery to later clinical research. We go all out to introduce innovative drugs into China more quickly and efficiently, and at the same time focus on the research of high-risk diseases in Asia-Pacific, such as liver disease and diabetes, and make use of the increasingly perfect biomedical ecosystem to actively promote the development of scientific research, including translational medicine, to meet the urgent needs of China patients in the field of diseases. Since its establishment, R&D Center has carried out more than 30 strategic cooperation with domestic authoritative scientific research institutions, and joined hands with China scientists to explore innovative drugs.
Prescription drugs: Sanofi has innovative products in the fields of cardiovascular diseases, diabetes, tumors, central nervous system diseases and internal medicine diseases. Pay attention to the needs of patients and fully meet the public health needs of China.
Vaccine: Sanofi Pasteur is Sanofi's vaccine division and the world's leading vaccine manufacturer. Sanofi Pasteur has innovative vaccine products in the field of preventing influenza, pneumonia and childhood diseases, and actively participates in and promotes the development of preventive immunization in China.
Health medicine industry: On 20 10- 10, Sanofi and Minsheng Medicine Group jointly established Hangzhou Sanofi Minsheng Health Medicine Co., Ltd., and Sanofi holds a majority stake in the joint venture company. On February 20 1 1, Sanofi completed the acquisition of BMP Sunstone and became a leading health pharmaceutical enterprise in China, with high-quality products in vitamin and mineral supplements and colds and coughs.
Rare diseases: Genzyme is one of the leading biotechnology companies in the world and a global leader in the field of rare diseases. 20 1 1, Jane agreed to be a subsidiary of sanofi group. In China 16, Jianzan helped more than 130 patients with Gaucher's disease to get a new life through charitable aid. Since 2006, we have actively promoted the policy of rare diseases, improved the drug accessibility of patients with rare diseases in China, and unswervingly promoted the development of rare diseases in China.
Animal health: Meria is the animal health department of Sanofi Group, leading the global animal health industry. At present, Meria has three joint ventures and one trading company in China, which mainly produces and sells poultry vaccine products, which are used to prevent and treat various diseases that infect broilers and laying hens, and provide related immune devices and immune supporting services. Meanwhile, imported vaccines and chemical products for pigs and pets in Melia are also widely recommended brands by domestic veterinarians and professionals.